Rebastinib is a non-ATP-Competitive Bcr-Abl Inhibitor
Abl1 proto-oncogene encodes a cytoplasmic and nuclear protein tyrosine kinase. Specifically, it is relevant to cell differentiation, cell division, cell adhesion, and stress response. Deletion of SH3 domain makes Abl1…